Cancer vaccine for dogs
US10138488B2 · kind B2 · utility
2Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2014 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Mar 28, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/07049
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a dog telomerase deprived of telomerase catalytic activity, or a fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.